Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Understanding the Acid-Base Response to Respiratory Derangements: Finding, and Clinically Applying, the In Vivo Base Excess

MLA. Heldeweg, K. Berend, P. Schober, F. Duška

. 2024 ; 6 (12) : e1191. [pub] 20241216

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003021

OBJECTIVES: To evaluate the base excess response during acute in vivo carbon dioxide changes. DESIGN: Secondary analysis of individual participant data from experimental studies. SETTING: Three experimental studies investigating the effect of acute in vivo respiratory derangements on acid-base variables. SUBJECTS: Eighty-nine (canine and human) carbon dioxide exposures. INTERVENTIONS: Arterial carbon dioxide titration through environmental chambers or mechanical ventilation. MEASUREMENTS AND MAIN RESULTS: For each subject, base excess was calculated using bicarbonate and pH using a fixed buffer power of 16.2. Analyses were performed using linear regression with arterial dioxide (predictor), base excess (outcome), and studies (interaction term). All studies show different baselines and slopes for base excess across carbon dioxide titrations methods. Individual subjects show substantial, and potentially clinically relevant, variations in base excess response across the hypercapnic range. Using a mathematical simulation of 10,000 buffer power coefficients we determined that a coefficient of 12.1 (95% CI, 9.1-15.1) instead of 16.2 facilitates a more conceptually appropriate in vivo base excess equation for general clinical application. CONCLUSIONS: In vivo changes in carbon dioxide leads to changes in base excess that may be clinically relevant for individual patients. A buffer power coefficient of 16.2 may not be appropriate in vivo and needs external validation in a range of clinical settings.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003021
003      
CZ-PrNML
005      
20250206104017.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/CCE.0000000000001191 $2 doi
035    __
$a (PubMed)39691548
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Heldeweg, Micah L A $u Department of Anesthesiology, Amsterdam University Medical Centers, Amsterdam, The Netherlands $u Department of Anaesthesia and Intensive Care Medicine, The Third Faculty of Medicine, Charles University and FNKV University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000174208486
245    10
$a Understanding the Acid-Base Response to Respiratory Derangements: Finding, and Clinically Applying, the In Vivo Base Excess / $c MLA. Heldeweg, K. Berend, P. Schober, F. Duška
520    9_
$a OBJECTIVES: To evaluate the base excess response during acute in vivo carbon dioxide changes. DESIGN: Secondary analysis of individual participant data from experimental studies. SETTING: Three experimental studies investigating the effect of acute in vivo respiratory derangements on acid-base variables. SUBJECTS: Eighty-nine (canine and human) carbon dioxide exposures. INTERVENTIONS: Arterial carbon dioxide titration through environmental chambers or mechanical ventilation. MEASUREMENTS AND MAIN RESULTS: For each subject, base excess was calculated using bicarbonate and pH using a fixed buffer power of 16.2. Analyses were performed using linear regression with arterial dioxide (predictor), base excess (outcome), and studies (interaction term). All studies show different baselines and slopes for base excess across carbon dioxide titrations methods. Individual subjects show substantial, and potentially clinically relevant, variations in base excess response across the hypercapnic range. Using a mathematical simulation of 10,000 buffer power coefficients we determined that a coefficient of 12.1 (95% CI, 9.1-15.1) instead of 16.2 facilitates a more conceptually appropriate in vivo base excess equation for general clinical application. CONCLUSIONS: In vivo changes in carbon dioxide leads to changes in base excess that may be clinically relevant for individual patients. A buffer power coefficient of 16.2 may not be appropriate in vivo and needs external validation in a range of clinical settings.
650    _2
$a lidé $7 D006801
650    12
$a oxid uhličitý $x metabolismus $7 D002245
650    _2
$a zvířata $7 D000818
650    12
$a acidobazická rovnováha $x fyziologie $7 D000136
650    _2
$a psi $7 D004285
650    _2
$a poruchy acidobazické rovnováhy $x patofyziologie $x metabolismus $7 D000137
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a hyperkapnie $x patofyziologie $x metabolismus $7 D006935
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a dospělí $7 D000328
650    _2
$a umělé dýchání $7 D012121
655    _2
$a časopisecké články $7 D016428
700    1_
$a Berend, Kenrick $u Department of Internal Medicine, Curaçao Medical Center, Willemstad, Curaçao
700    1_
$a Schober, Patrick $u Department of Anesthesiology, Amsterdam University Medical Centers, Amsterdam, The Netherlands
700    1_
$a Duška, František $u Department of Anaesthesia and Intensive Care Medicine, The Third Faculty of Medicine, Charles University and FNKV University Hospital, Prague, Czech Republic
773    0_
$w MED00203269 $t Critical care explorations $x 2639-8028 $g Roč. 6, č. 12 (2024), s. e1191
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39691548 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104013 $b ABA008
999    __
$a ok $b bmc $g 2263046 $s 1239028
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 6 $c 12 $d e1191 $e 20241216 $i 2639-8028 $m Critical care explorations $n Crit Care Explor $x MED00203269
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...